Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 10, Pages 1103-1114
Publisher
Informa UK Limited
Online
2017-08-17
DOI
10.1080/13543784.2017.1369042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased choroidal mast cells and their degranulation in age-related macular degeneration
- (2016) Imran A Bhutto et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Brimonidine Can PreventIn VitroHydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells
- (2016) Claudio Ramírez et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study)
- (2016) Robert B. Bhisitkul et al. OPHTHALMOLOGY
- Relationship between Oxidative Stress, Circadian Rhythms, and AMD
- (2016) María Luisa Fanjul-Moles et al. Oxidative Medicine and Cellular Longevity
- Risk factors and biomarkers of age-related macular degeneration
- (2016) Nathan G. Lambert et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration
- (2015) O. Levy et al. EMBO Molecular Medicine
- Antibody therapies and their challenges in the treatment of age-related macular degeneration
- (2015) Cornelia Volz et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation
- (2015) Mohammad Ali Sadiq et al. Expert Opinion On Drug Safety
- A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
- (2015) Lars G Fritsche et al. NATURE GENETICS
- Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients
- (2015) Won Kyung Song et al. Stem Cell Reports
- Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD
- (2014) Sayak K Mitter et al. Autophagy
- Geographic Atrophy
- (2014) Frank G. Holz et al. OPHTHALMOLOGY
- Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study
- (2014) Thomas Leyhe et al. Alzheimers Research & Therapy
- Relationship between Systemic Cytokines and Complement Factor H Y402H Polymorphism in Patients With Dry Age-Related Macular Degeneration
- (2013) Sijia Cao et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Chaperone-mediated autophagy: roles in disease and aging
- (2013) Ana Maria Cuervo et al. CELL RESEARCH
- Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis
- (2013) Nathan R. Selden et al. Journal of Neurosurgery-Pediatrics
- New hope for dry AMD?
- (2013) James B. Evans et al. NATURE REVIEWS DRUG DISCOVERY
- Autophagy in Human Health and Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Clinical Classification of Age-related Macular Degeneration
- (2013) Frederick L. Ferris et al. OPHTHALMOLOGY
- Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
- (2013) Zohar Yehoshua et al. OPHTHALMOLOGY
- PHASE 1, DOSE-RANGING STUDY OF EMIXUSTAT HYDROCHLORIDE (ACU-4429), A NOVEL VISUAL CYCLE MODULATOR, IN HEALTHY VOLUNTEERS
- (2013) Ryo Kubota et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Prevalence and Risk Factors for Age-Related Macular Degeneration in Indians: A Comparative Study in Singapore and India
- (2012) Chui Ming Gemmy Cheung et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The estimated prevalence and incidence of late stage age related macular degeneration in the UK
- (2012) Christopher G Owen et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88
- (2012) Valeria Tarallo et al. CELL
- Mitochondrial Dysfunction in Retinal Diseases
- (2012) Megha Barot et al. CURRENT EYE RESEARCH
- Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration
- (2012) Trevor J. McGill et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Embryonic stem cell trials for macular degeneration: a preliminary report
- (2012) Steven D Schwartz et al. LANCET
- Mechanism of Inflammation in Age-Related Macular Degeneration
- (2012) Francesco Parmeggiani et al. MEDIATORS OF INFLAMMATION
- NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components
- (2012) Sarah L Doyle et al. NATURE MEDICINE
- INVESTIGATION OF ORAL FENRETINIDE FOR TREATMENT OF GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION
- (2012) Nathan L. Mata et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination
- (2012) N. Uchida et al. Science Translational Medicine
- Neural Stem Cell Engraftment and Myelination in the Human Brain
- (2012) N. Gupta et al. Science Translational Medicine
- Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks
- (2012) Aaron M Newman et al. Genome Medicine
- DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
- (2011) Hiroki Kaneko et al. NATURE
- A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
- (2011) Siobhan M. Cashman et al. PLoS One
- SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR
- (2011) Ryo Kubota et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Oxidation and age-related macular degeneration: insights from molecular biology
- (2010) Sam Khandhadia et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Transcriptome analysis and molecular signature of human retinal pigment epithelium
- (2010) N.V. Strunnikova et al. HUMAN MOLECULAR GENETICS
- Therapieansätze bei geographischer Atrophie
- (2010) S. Schmitz-Valckenberg et al. OPHTHALMOLOGE
- Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration
- (2009) S. Cherepanoff et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited
- (2009) Don H. Anderson et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Fundus Autofluorescence and Progression of Age-related Macular Degeneration
- (2009) Steffen Schmitz-Valckenberg et al. SURVEY OF OPHTHALMOLOGY
- Variation near complement factor I is associated with risk of advanced AMD
- (2008) Jesen A Fagerness et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA
- (2008) Lars G Fritsche et al. NATURE GENETICS
- Oxidative damage–induced inflammation initiates age-related macular degeneration
- (2008) Joe G Hollyfield et al. NATURE MEDICINE
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-related Macular Degeneration and Complement Activation–related Diseases
- (2008) Dorothea Nitsch et al. OPHTHALMOLOGY
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More